表紙
市場調査レポート

競合分析:G-CSFおよびGM-CSF

Competitor Analysis: G-CSF and GM-CSF

発行 La Merie Publishing 商品コード 269004
出版日 ページ情報 英文 72 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
競合分析:G-CSFおよびGM-CSF Competitor Analysis: G-CSF and GM-CSF
出版日: 2013年04月22日 ページ情報: 英文 72 Pages
概要

当レポートでは、規制市場および規制緩和市場におけるG-CSFおよびGM-CSFブランド製品、バイオシミラー、および長時間作用型製品について調査し、薬剤コード、標的/作用機序、化合物クラス、企業、製品分類、適応症、R&D段階などの情報を提供しており、概略以下の構成でお届けいたします。

目次

  • 規制市場におけるブランドG-CSF製品の売上
  • 規制市場における第1世代ブランドG-CSF製品
  • 規制市場における第1世代バイオシミラーG-CSF製品
  • 規制市場における次世代ブランドG-CSF製品
  • 規制市場における次世代バイオシミラーG-CSF製品
  • 規制緩和市場における第1世代G-CSF製品:インド
  • 規制緩和市場における第1世代G-CSF製品:中国・台湾
  • 規制緩和市場における第1世代G-CSF製品:韓国
  • 規制緩和市場における第1世代G-CSF製品:ラテンアメリカ
  • 規制緩和市場における第1世代G-CSF製品:その他の地域
  • 規制緩和市場における次世代G-CSF製品
  • 規制市場における次世代GM-CSF製品
  • 規制緩和市場における次世代GM-CSF製品
目次
Product Code: LMCA0036

Abstract

Product description

The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products in regulated markets and products in non-regulated markets, biosimilars (biogenerics, follow-on biologics) and next generation, longer acting products as of April 2013. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently marketed branded and non-branded G-CSF and GM-CSF products in regulated and non-regulated markets for treatment of chemotherapy-induced neutropenia. The report includes the market size of branded G-CSF products in 2012. It lists the most advanced biosimilars of G-CSF and next generation G-CSF and of GM-CSF in regulated markets and non-regulated markets. In addition, the report lists company-specific product portfolios and R&D pipelines of G-CSF/GM-CSF products and projects. Competitor projects are listed in a tabular format providing information on:

  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

Table of Contents

  • 2012 Sales of Branded G-CSF Products in Regulated Markets
  • 1st Generation Branded G-CSF Products in Regulated Markets
  • Biosimilar 1st Generation G-CSF Products in Regulated Markets
  • Next Generation Branded G-CSF Products in Regulated Markets
  • Biosimilar Next Generation G-CSF Products in Regulated Markets
  • 1st Generation G-CSF Products in Non-Regulated Markets: India
  • 1st Generation G-CSF Products in Non-Regulated Markets: China & Taiwan
  • 1st Generation G-CSF Products in Non-Regulated Markets - Korea
  • 1st Generation G-CSF Products in Non-Regulated Markets - Latin America
  • 1st Generation G-CSF Products in Non-Regulated Markets: Other Territories
  • Next Generation G-CSF Products in Non-Regulated Markets
  • 1st and Next Generation GM-CSF Products in Regulated Markets
  • 1st and Next Generation GM-CSF Products in Non-Regulated Markets
Back to Top